teva pharmaceuticals introduces the first generic glp-1 for weight loss FDA approval FDA Approves First Generic GLP-1

Responsible evaluation prioritizes health and informed consent

CJC 1295 is a synthetic peptide designed to stimulate the release of growth hormone, making it highly popular in fitness and bodybuilding communities (similar to how BPC 157 is loved by the gym community)

Karagiannis T, Avgerinos I, Liakos A et al (2022) Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis

Food and Drug Administration does not review the safety and efficacy of compounded products, and the agency has urged consumers to take the approved, branded GLP-1 medications when they are available